精选行业洞察美国 FDAT1072
FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
🤖 AI 摘要
The U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone hydrochloride nasal spray for the emergency treatment of opioid overdose.
分析模型：rule-based-v3 · 07-09 06:59
评分详情
综合分 72/100
信源权威
95
影响范围
75
时效性
50
合规紧急
40
行业关注
75
FDA Press Releases (新闻发布)
操作：